Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

136 PROCARE – phase 2 KCE reports 81PROPORTION OF (Y)PSTAGE III PATIENTS WITH R0 RESECTIONTHAT RECEIVED ADJUVANT CHEMOTHERAPYMeasurement in prospective PROCARE database (Figure 46)Patients with (y)pStage III RC are selected through variable ‘PT_V151’. Those patientsundergoing R0 resection are selected using variable ‘SG_V216’ (subcode 1). Patientsreceiving adjuvant chemotherapy without radiotherapy are selected with variables‘CH_V105’ (subcode 3) and ‘CH_V106’ (subcode not 2).Measurement in coupled administrative databaseSelection of (y)pStage III patients can be done easily using the BCR database. Above this,accurate information is available on the use of adjuvant chemotherapy (Table 72).However, no administrative code exists for R0 resection. Therefore, this QI is notmeasurable for the administrative cohort.Figure 46. Algorithm for QI 1241 (prospective database).All patientsN=1071SurgeryN=296Adjuvant chemotherapy only(without adjuvant radiotherapy)N=2021,28%Stage?pyp-Stage IIIN=296Type ofresection?R0 resectionN=246Adjuvant chemotherapywith adjuvant radiotherapyN=3Surgery?Treatmentafter surgery?Adjuvant chemotherapy(no info radiotherapy)N=11No surgeryN=0Adjuvant radiotherapy(without adjuvant chemotherapy)N=0pyp-Stage 0-I-II-IVN=594R1 resectionR2 resectionUncertainN=43Adjuvant radiotherapy(no info chemotherapy)N=0pyp-Stage UnknownN=181Type of resectionMISSINGN=7No adjuvant treatmentN=71No adjuvant treatment=MISSINGN=141
KCE Reports 81 PROCARE – phase 2 137PROPORTION OF PSTAGE II-III PATIENTS WITH R0 RESECTIONTHAT RECEIVED ADJUVANT RADIOTHERAPY ORCHEMORADIOTHERAPYMeasurement in prospective PROCARE database (Figure 47)Patients with pStage II-III RC are selected through variable ‘PT_V151’. Those patientsundergoing R0 resection are selected using variable ‘SG_V216’ (subcode 1). Patientsreceiving adjuvant radio(chemo)therapy are selected with variables ‘RD_V101’ (subcode2) and ‘RD_V124’ (subcode 1 if without chemotherapy, subcode 2 if withchemotherapy).Measurement in coupled administrative databaseSelection of pStage II-III patients can be done easily using the BCR database. Above this,accurate information is available on the use of adjuvant radio(chemo)therapy (Table 70,71 and 72). However, no administrative code exists for R0 resection. Therefore, this QIis not measurable for the administrative cohort.Figure 47. Algorithm for QI 1242 (prospective database).All patientsN=1071SurgeryN=226Adjuvant chemotherapy only(without adjuvant radiotherapy)N=2Stage?p-Stage II-IIIN=226Type ofresection?R0 resectionN=193Adjuvant radiotherapyor adjuvant chemoradioN=86,61%Surgery?Treatmentafter surgery?p-Stage 0-I-IVN=139R1 resectionR2 resectionUncertainN=28Adjuvant chemotherapy(no info radiotherapy)N=12p-Stage UnknownN=5Not applicable(only yp)N=701No surgeryN=0Type of resectionMISSINGN=5No adjuvant treatmentN=111Adjuvant treatment:MISSINGN=60
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
KCE Reports 81 PROCARE - Phase 2 77
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96: KCE Reports 81 PROCARE - phase 2 85
Page 145: KCE Reports 81 PROCARE - phase 2 13
Page 169: KCE Reports 81 PROCARE - phase 2 15
Page 172 and 173: Dépôt légal : D/2008/10.273/39
Page 174 and 175: 35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?